N. Kyprianou et S. Rock, RADIATION-INDUCED APOPTOSIS OF HUMAN PROSTATE-CANCER CELLS IS INDEPENDENT OF MUTANT P53 OVEREXPRESSION, Anticancer research, 18(2A), 1998, pp. 897-905
Background: Previous studies have demonstrated that androgen-independe
nt prostate cancer cells undergo apoptosis in response to ionizing irr
adiation. The p53 protein controls cell cycle nn est and apoptosis by
acting as a checkpoint control that halts the cell cycle in G1, while
DNA damage is present, in this study the effect of overexpression of m
utant p53 protein, on radiation-induced apoptotic cell death of human
prosrate cancer cells PC-3 was investigated. Materials and Methods: PC
-3 cells were transfected with the plasmid encoding the mutant p53 seq
uence, and the neomycin resistance gene. Selected transfectant clones,
were characterized at the molecular level (gene integration, and leve
l of mRNA and protein expression) and cloned transfectants expressing
high levels of p53 protein were treated with increasing doses of ioniz
ing ii-radiation. The cellular response to radiation was determined on
the basis of: a) clonogenic survival (colony forming ability of irrad
iated cells); b) induction of apoptosis as determined by the terminal
transferase assay; c) apoptotic DNA fragmentation; and d) induction of
expression of genes associated with prostate-apoptosis. Results: Both
mutant p53 transfectant and parental PC-3 cells underwent apoptosis i
n response to ionizing irradiation following similar kinetics of induc
tion of DNA fragmentation. In addition the magnitude of induction of e
xpression of prostate apoptosis associated genes, SGP-2 and TGF-beta,
was similar in the mutant p53 overexpressing and parental PC-3 cells a
nd coincidental with DNA fragmentation. Conclusions: These findings se
riously challenge the involvement of p53 in radiation-induced apoptosi
s in human prostate cancel cells and suggest that p53 mutations provid
e no selective advantage in the development of radioresistance of pros
tate tumor cells within the context of p53-independent apoptotic pathw
ay.